Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy-Reference-Cited by-同舟云学术

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy

Published:2001-04 Issue:2 Volume:24 Page:275-290
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:J Inherit Metab Dis

Author:

Platt F. M.¹,Jeyakumar M.¹,Andersson U.¹,Priestman D. A.¹,Dwek R. A.¹,Butters T. D.¹,Cox T. M.²,Lachmann R. H.²,Hollak C.³,Aerts J. M. F. G.³,Van Weely S.³,Hrebícek M.⁴,Moyses C.⁵,Gow I.⁵,Elstein D.⁶,Zimran A.⁶

Affiliation:

1. ; Glycobiology Institute, Department of Biochemistry; University of Oxford; Oxford UK

2. ; Department of Medicine; University of Cambridge; Addenbrooke's Hospital Cambridge UK

3. ; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands

4. Institute of Inherited Metabolic Disorders; Prague Czech Republic

5. Oxford GlycoSciences; Abingdon UK

6. ; Shaare Zedek Medical Center; Jerusalem Israel

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1023/A:1010335505357/fullpdf

Reference46 articles.

1. Plasma and metabolic abnormalities in Gaucher's disease;Aerts;Baillières Clin Haematol,1997

2. N-butyldeoxygalactonojirimycin; a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo;Andersson;J Biochem Pharmacol,2000

3. Biology and potential strategies for the treatment of G(M2) gangliosides;Chavany;Mol Med Today,1990

4. Partial enzyme deficiencies: residual activities and the development of neurological disorders;Conzelmann;Dev Neurosci,1983

5. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis;Cox;Lancet,2000

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction;Molecules;2024-01-17

2. GM1 Gangliosidosis;Genetic Syndromes;2023

3. Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis;Nature Communications;2022-10-07

4. Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease;Scientific Reports;2022-06-04

5. HEPES‐buffering of bicarbonate‐containing culture medium perturbs lysosomal glucocerebrosidase activity;Journal of Cellular Biochemistry;2022-03-21